UBE2Q1 and acute lymphoblastic leukemia: However, while the necessity of extending investigation on this gene and on a larger number of samples still exists, our data suggest that the novel human gene, UBE2Q1, might be potentially a useful molecular marker and a candidate for drug targeting to treat ALL in the future.